Pyroptosis-boosting nanoadjuvants enable effective in situ cancer vaccination

Pyroptosis-boosting nanoadjuvants enable effective in situ cancer vaccination

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Chen, B. et al. In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy. Nat. Mater. https://doi.org/10.1038/s41563-026-02506-9 (2026).